Brokerages Set Indivior PLC (NASDAQ:INDV) Target Price at $22.00

Shares of Indivior PLC (NASDAQ:INDVGet Free Report) have received an average rating of “Moderate Buy” from the eight research firms that are currently covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, five have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $22.00.

INDV has been the subject of several research reports. Jefferies Financial Group initiated coverage on Indivior in a research note on Tuesday, July 22nd. They issued a “buy” rating and a $20.00 target price for the company. Zacks Research downgraded Indivior from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 3rd. Weiss Ratings reiterated a “hold (c-)” rating on shares of Indivior in a research note on Wednesday. Wall Street Zen upgraded Indivior from a “buy” rating to a “strong-buy” rating in a research note on Saturday, June 21st. Finally, HC Wainwright began coverage on Indivior in a research note on Wednesday, August 6th. They set a “buy” rating and a $27.00 price target for the company.

Check Out Our Latest Stock Analysis on Indivior

Hedge Funds Weigh In On Indivior

A number of hedge funds have recently added to or reduced their stakes in the stock. Mirae Asset Global Investments Co. Ltd. boosted its stake in Indivior by 16.0% during the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 4,820 shares of the company’s stock valued at $71,000 after purchasing an additional 666 shares during the last quarter. Raymond James Financial Inc. bought a new position in shares of Indivior during the 2nd quarter worth approximately $26,000. Y Intercept Hong Kong Ltd lifted its position in shares of Indivior by 17.4% during the 2nd quarter. Y Intercept Hong Kong Ltd now owns 25,443 shares of the company’s stock worth $375,000 after buying an additional 3,769 shares in the last quarter. Amalgamated Bank bought a new position in shares of Indivior during the 2nd quarter worth approximately $61,000. Finally, California State Teachers Retirement System bought a new position in shares of Indivior during the 2nd quarter worth approximately $112,000. Institutional investors and hedge funds own 60.33% of the company’s stock.

Indivior Price Performance

Shares of INDV opened at $23.78 on Friday. The stock has a 50-day moving average of $23.51 and a 200-day moving average of $16.48. The company has a market cap of $3.28 billion, a PE ratio of 38.36 and a beta of 0.70. Indivior has a one year low of $7.33 and a one year high of $25.10.

Indivior (NASDAQ:INDVGet Free Report) last issued its earnings results on Thursday, July 31st. The company reported $0.51 EPS for the quarter, beating the consensus estimate of $0.26 by $0.25. The company had revenue of $302.00 million during the quarter, compared to the consensus estimate of $239.43 million. Indivior had a negative return on equity of 86.28% and a net margin of 6.65%. Indivior has set its FY 2025 guidance at EPS. Analysts expect that Indivior will post 1.22 EPS for the current fiscal year.

About Indivior

(Get Free Report)

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.

Read More

Analyst Recommendations for Indivior (NASDAQ:INDV)

Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.